Chemoinformaics analysis of (2S)-1-METHYL-2-PROPYLPIPERIDINE
| Molecular Weight | 141.258 | nRot | 2 |
| Heavy Atom Molecular Weight | 122.106 | nRig | 2 |
| Exact Molecular Weight | 141.152 | nRing | 1 |
| Solubility: LogS | -3.393 | nHRing | 1 |
| Solubility: LogP | 3.731 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.7991 |
| nHD | 0 | BPOL | 20.7709 |
| QED | 0.36 |
| Synth | 2.161 |
| Natural Product Likeliness | 1.422 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.041 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.321 |
| MDCK | 0.0000191 |
| BBB | 0.333 |
| PPB | 0.923906 |
| VDSS | 1.016 |
| FU | 0.106004 |
| CYP1A2-inh | 0.975 |
| CYP1A2-sub | 0.857 |
| CYP2c19-inh | 0.875 |
| CYP2c19-sub | 0.643 |
| CYP2c9-inh | 0.704 |
| CYP2c9-sub | 0.646 |
| CYP2d6-inh | 0.559 |
| CYP2d6-sub | 0.124 |
| CYP3a4-inh | 0.408 |
| CYP3a4-sub | 0.203 |
| CL | 9.652 |
| T12 | 0.645 |
| hERG | 0.069 |
| Ames | 0.006 |
| ROA | 0.018 |
| SkinSen | 0.926 |
| Carcinogencity | 0.103 |
| EI | 0.992 |
| Respiratory | 0.613 |
| NR-Aromatase | 0.051 |
| Antiviral | No |
| Prediction | 0.947817 |